600161.SH
天坛生物
SSE · Healthcare · Biotechnology · CN
CNY 11.94
−1.73%Next report
Analyst consensus
- Next report date
- Oct 22, 2026
- EPS estimate
- CNY 0.11
- Revenue estimate
- CNY 1.0B
Latest reported
- Last report date
- Aug 28, 2026
- EPS actual
- CNY 0.14
- EPS estimate
- CNY 0.09
- Revenue actual
- CNY 1.4B
- Revenue estimate
- CNY 1.2B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +52.2%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 22, 2026